Molecular Templates Inc (MTEM)
NASDAQ:MTEM
US Market
Holding MTEM?
Track your performance easily

Molecular Templates (MTEM) Stock Price & Analysis

536 Followers

MTEM Stock Chart & Stats


Financials

Annual

Ownership Overview

45.98%1.50%0.05%51.71%
45.98% Insiders
0.05% Other Institutional Investors
51.71% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

MTEM FAQ

What was Molecular Templates Inc’s price range in the past 12 months?
Molecular Templates Inc lowest stock price was $0.29 and its highest was $6.25 in the past 12 months.
    What is Molecular Templates Inc’s market cap?
    Currently, no data Available
    When is Molecular Templates Inc’s upcoming earnings report date?
    Molecular Templates Inc’s upcoming earnings report date is Nov 11, 2024 which is tomorrow.
      How were Molecular Templates Inc’s earnings last quarter?
      Molecular Templates Inc released its earnings results on Aug 14, 2024. The company reported -$1.23 earnings per share for the quarter, beating the consensus estimate of -$1.44 by $0.21.
        Is Molecular Templates Inc overvalued?
        According to Wall Street analysts Molecular Templates Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Molecular Templates Inc pay dividends?
          Molecular Templates Inc does not currently pay dividends.
          What is Molecular Templates Inc’s EPS estimate?
          Molecular Templates Inc’s EPS estimate is -$1.03.
            How many shares outstanding does Molecular Templates Inc have?
            Molecular Templates Inc has 6,583,880 shares outstanding.
              What happened to Molecular Templates Inc’s price movement after its last earnings report?
              Molecular Templates Inc reported an EPS of -$1.23 in its last earnings report, beating expectations of -$1.44. Following the earnings report the stock price went up 4.93%.
                Which hedge fund is a major shareholder of Molecular Templates Inc?
                Among the largest hedge funds holding Molecular Templates Inc’s share is Invst, LLC. It holds Molecular Templates Inc’s shares valued at 21K.
                  ---

                  Molecular Templates Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -91.67%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  Trailing 12-Months
                  Asset Growth
                  -24.82%
                  Trailing 12-Months

                  Company Description

                  Molecular Templates Inc

                  Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded on October 17, 2001 and is headquartered in Austin, TX.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Adaptimmune Therapeutics
                  Corvus Pharmaceuticals
                  Cellectar Biosciences
                  Gritstone bio
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis